KNSA — Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing th...
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating cardiovascular diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and Vixarelimab. Geographically, the company earns maximum revenue from United States.
- Industry
- PHARMACEUTICAL PREPARATIONS
- Sector
- Healthcare
- Exchange
- NASD
- First trade date
- 2018-05-24
The interactive platform loads with JavaScript. Research tools are for informational purposes.